SS
ANRO icon

SBI Securities’s Alto Neuroscience ANRO Stock Holding History

SBI Securities’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317 Hold
12
– – ﹤0.01% 3184
2026
Q1 		$270 Hold
12
– – ﹤0.01% 3110
2025
Q4 		$214 Buy
12
+9
+300% +$113 ﹤0.01% 3192
2025
Q3 		$12 Sell
3
-43
-93% -$143 ﹤0.01% 4016
2025
Q2 		$101 Hold
46
– – ﹤0.01% 3539
2025
Q1 		$99 Buy
46
+33
+254% +$118 ﹤0.01% 3445
2024
Q4 		$55 Buy
+13
New +$81 ﹤0.01% 3617

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SBI Securities's ANRO Position: Q2 2026 in Review

SBI Securities held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 12 shares worth $317. The position accounts for ﹤0.01% of the portfolio, ranked #3184.

SBI Securities first reported a position in ANRO in Q4 2024 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • SBI Securities held 12 shares of Alto Neuroscience worth $317 as of Q2 2026.
  • SBI Securities left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3184 holding.
  • SBI Securities first reported a position in Alto Neuroscience in Q4 2024 and has held it in 7 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.